Pharma News
Stakeholder Capitalism: Q&A with Meg Alexander, Chief Strategy Officer at Ovid Therapeutics (Part 2)
Alexander continues her conversation, touching on topics like disinformation and diversity in clinical trials.
Source link
#Stakeholder #Capitalism #QampA #Meg #Alexander #Chief #Strategy #Officer #Ovid #Therapeutics #Part